DUBLIN–(BUSINESS WIRE)–The “Global Precision Medicine Software Market 2020-2024” report has been added to ResearchAndMarkets.com’s offering.

The publisher has been monitoring the global precision medicine software market and it is poised to grow by USD 882.65 mn during 2020-2024, progressing at a CAGR of 11% during the forecast period.

The report on the global precision medicine software market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by benefits of precision medicine. In addition, digitization of healthcare is anticipated to boost the growth of the global precision medicine software market as well.

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • Preface
  • Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
  • Value Chain Analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market Outlook
  • Market size and forecast 2019-2024

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY DELIVERY MODE

  • Market segmentation by delivery mode
  • Comparison by delivery mode
  • On-premise – Market size and forecast 2019-2024
  • Cloud-based – Market size and forecast 2019-2024
  • Market opportunity by delivery mode

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America – Market size and forecast 2019-2024
  • Europe – Market size and forecast 2019-2024
  • Asia – Market size and forecast 2019-2024
  • ROW – Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Rise in clinical trials in developing nations
  • Digitization of healthcare
  • Improvement in healthcare and IT infrastructure in emerging economies

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • F. Hoffmann-La Roche Ltd.
  • Fabric Genomics, Inc.
  • Gene42 Inc.
  • Human Longevity, Inc.
  • International Business Machines Corp.
  • Koninklijke Philips NV
  • NantHealth Inc.
  • Roper Technologies Inc.
  • SOPHiA GENETICS SA
  • Syapse Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

For more information about this report visit https://www.researchandmarkets.com/r/8cz0op

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.